Mutations in ZMYM4 are associated with severe childhood obesity (Greenhill, 2020; Marenne et al., 2020; Regan and Shah, 2020), schizophrenia (Xiang et al., 2020), heritable substance use disorders (Zhang et al., 2022), heritable sleep disorders (Spada et al., 2016), and cancers (Goyal et al., 2017; Goyal et al., 2017; Goyal et al., 2019; Goyal et al., 2021; Moon et al., 2021; Yu et al., 2023). This evidence concerns the gene ZMYM4 and cancer.